|Articles|June 8, 2016

Contagion Digital News Resource Unveils Global Outbreak Monitor for Zika, Ebola, Yellow Fever, and Other Infectious Diseases

Contagion has launched a global Outbreak Monitor that allows users to visualize occurrences of infectious diseases, such as Zika and Yellow Fever, on a local, regional, national and international level.

PLAINSBORO, N.J. (June 8, 2016) — Contagion™, a fully-integrated digital news resource for practitioners and specialists working in infectious diseases, has launched a global Outbreak Monitor that allows users to visualize occurrences of infectious diseases, such as Zika and Yellow Fever, on a local, regional, national and international level. The Monitor also tracks trends and details on the number of confirmed cases and deaths matched with recent Contagion website articles on disease topics.

Targeting health care professionals working and interested in infectious diseases, as well as the general consumer media, the Outbreak Monitor is regularly updated with information and details from trusted global reporting organizations, including the Centers for Disease Control and Prevention, World Health Organization, National Institutes of Health, and the US Department of Health and Human Services.

“Resources, such as the Outbreak Monitor, can help both clinicians and the public keep in mind both that infectious diseases are ever-present and that continued surveillance is essential to see where to best aim our efforts to control them,” said Jason C. Gallagher, Pharm.D., FCCP, FIDSA, BCPS, president of the Society of Infectious Diseases Pharmacists. “The Monitor can help remind the public that outbreaks are not just something they read about in the newspaper or see on TV - they can hit close to home.”

Jeff Prescott, PharmD, RPh, senior vice president of clinical affairs at Michael J. Hennessy Associates Inc., which produces Contagion, added, “Given the severity of some infectious diseases and the increase of global travel, it’s important that health care professionals stay up-to-date on the latest outbreak information, both near and afar, in order to anticipate infections and take the proper steps toward infection prevention. Our Outbreak Monitor covers Zika, Ebola, Yellow Fever, and a number of other emerging conditions that health care specialists and the media can now track from a single, reliable source.”

As the all-inclusive resource for infectious diseases information, Contagion features the latest news, scientific research studies, original articles and commentary directly from leading experts, as well as conference coverage and video interviews with experts in the field. What sets Contagion apart from other news resources is an extensive editorial board that drives an active forum for the world’s top infectious diseases experts to come together to share relevant content to impact future infectious diseases practices.

About Contagion

Contagion is a fully-integrated print and digital news publication that provides health care practitioners and aligned professionals with timely information and resources to improve patient outcomes and positively impact the identification, diagnosis, treatment, and prevention of infectious diseases. Contagion is part of Michael J. Hennessy Associates Inc., a full-service health care communications company offering education, research and medical media.

# # #

Media Contact:

Michael J. LaCosta

Executive Director of Public Relations

mjlacosta@mjhassoc.com

551-655-3718


Related to this article

Ebola Outbreak Tops 10,000 Cases as CDC Cites Spread to Kenya, Nigeria
The CDC reports the Bundibugyo virus outbreak in the Democratic Republic of the Congo (DRC) is now the second-largest Ebola outbreak on record. As of October 28, the agency counted 10,305 total confirmed cases and 4,996 total confirmed deaths. The overall risk to the American public and travelers remains low, and no cases tied to this outbreak have been confirmed in the US.
Measles Update: October 30, 2026
The latest CDC numbers show a 5.8% increase in measles cases from week-to-week, bringing the 2026 US total to more than double the amount seen in all of 2025 with 2 months left in the year.
Cefiderocol Continues to Show Activity Against Resistant Gram-Negative Infections
Shionogi data presented at IDWeek 2026 demonstrated a 76.7% clinical response with cefiderocol in carbapenem-resistant respiratory infections and high in vitro activity against resistant P aeruginosa VAP isolates. Christine Slover, PharmD, vice president, Infectious Diseases US Medical Affairs, Shionogi, offers insights on the data as well as clinical considerations for providers when weighing the antibiotic for patients.